HilleVax Company Contacts

HilleVax

https://www.hillevax.com
HilleVax is a biopharmaceutical company focused on the development and commercialization of novel vaccines. Our initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate in development for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection.... Read More
Contacts

Country

United States

City

Boston

Headquarters

Boston, MA

Profile

Founded

2021

Industry

Biotechnology Research

Size

51 - 200

Funding

Total Rounds

2

Last Round

Mon Sep 18 2023

Last Round Series

Post IPO equity

Last Round Raised

$ 100,000,000